Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

LCZ696: the next step in improving RAS inhibition?

Gradman AH.

Curr Hypertens Rep. 2015 May;17(5):37. doi: 10.1007/s11906-015-0548-y.

PMID:
25833460
2.

Response to comment on "is addition of vasodilators to loop diuretics of value in the care of hospitalized acute heart failure patients? Real-world evidence from a retrospective analysis of a large United States hospital database".

Gradman AH, Vekeman F, Eldar-Lissai A, Trahey A, Duh MS, Ong SH.

J Card Fail. 2015 May;21(5):435. doi: 10.1016/j.cardfail.2015.03.003. Epub 2015 Mar 19. No abstract available.

PMID:
25796428
3.

Recent clinical trials.

Gradman AH, Basile JN.

J Am Soc Hypertens. 2014 Oct;8(10):770-4; quiz 775-6. doi: 10.1016/j.jash.2014.08.006. Epub 2014 Aug 15. No abstract available.

PMID:
25418501
4.

Is addition of vasodilators to loop diuretics of value in the care of hospitalized acute heart failure patients? Real-world evidence from a retrospective analysis of a large United States hospital database.

Gradman AH, Vekeman F, Eldar-Lissai A, Trahey A, Ong SH, Duh MS.

J Card Fail. 2014 Nov;20(11):853-63. doi: 10.1016/j.cardfail.2014.08.006. Epub 2014 Aug 21.

PMID:
25152497
5.

Optimal blood pressure targets in older adults: how low is low enough?

Gradman AH.

J Am Coll Cardiol. 2014 Aug 26;64(8):794-6. doi: 10.1016/j.jacc.2014.06.1153. No abstract available.

PMID:
25145523
6.

Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.

Giles TD, Weber MA, Basile J, Gradman AH, Bharucha DB, Chen W, Pattathil M; NAC-MD-01 Study Investigators.

Lancet. 2014 May 31;383(9932):1889-98. doi: 10.1016/S0140-6736(14)60614-0.

PMID:
24881993
7.

The impact of variability in ultrasound settings on the measured echolucency of the carotid intima-media.

Peters SA, Bots ML, Lind L, Groenewegen KA, de Korte C, den Ruijter HM; METEOR study group.

J Hypertens. 2013 Sep;31(9):1861-7. doi: 10.1097/HJH.0b013e3283623548.

PMID:
23868083
8.

Initial combination therapy reduces the risk of cardiovascular events in hypertensive patients: a matched cohort study.

Gradman AH, Parisé H, Lefebvre P, Falvey H, Lafeuille MH, Duh MS.

Hypertension. 2013 Feb;61(2):309-18. doi: 10.1161/HYPERTENSIONAHA.112.201566. Epub 2012 Nov 26.

9.

Effect of rosuvastatin on the echolucency of the common carotid intima-media in low-risk individuals: the METEOR trial.

Lind L, Peters SA, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR 3rd, O'Leary DH, Evans GW, Raichlen JS, Bots ML; METEOR Study Group.

J Am Soc Echocardiogr. 2012 Oct;25(10):1120-1127.e1. doi: 10.1016/j.echo.2012.07.004. Epub 2012 Aug 9.

PMID:
22884641
10.

Strategies for combination therapy in hypertension.

Gradman AH.

Curr Opin Nephrol Hypertens. 2012 Sep;21(5):486-91. doi: 10.1097/MNH.0b013e328356c551. Review.

PMID:
22871676
11.

Biologically implausible carotid intima-media thickness measurement values: effects on rate of change over time.

Peters SA, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR 3rd, O'Leary DH, Evans GW, Raichlen JS, Bots ML; METEOR Study Group.

Curr Med Res Opin. 2012 Jun;28(6):891-9. doi: 10.1185/03007995.2012.689255. Epub 2012 Jun 6.

PMID:
22536884
12.

Increased age, high body mass index and low HDL-C levels are related to an echolucent carotid intima-media: the METEOR study.

Peters SA, Lind L, Palmer MK, Grobbee DE, Crouse JR 3rd, O'Leary DH, Evans GW, Raichlen J, Bots ML, den Ruijter HM; METEOR study group.

J Intern Med. 2012 Sep;272(3):257-66. doi: 10.1111/j.1365-2796.2011.02505.x. Epub 2012 Jan 12.

PMID:
22172243
13.
14.

Extensive or restricted ultrasound protocols to measure carotid intima-media thickness: analysis of completeness rates and impact on observed rates of change over time.

Peters SA, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR 3rd, O'Leary DH, Evans GW, Raichlen JS, Bots ML; METEOR Study Investigators.

J Am Soc Echocardiogr. 2012 Jan;25(1):91-100. doi: 10.1016/j.echo.2011.09.009. Epub 2011 Oct 7.

PMID:
21982737
15.

Algorithms to measure carotid intima-media thickness in trials: a comparison of reproducibility, rate of progression and treatment effect.

Dogan S, Plantinga Y, Crouse JR 3rd, Evans GW, Raichlen JS, O'Leary DH, Palmer MK, Grobbee DE, Bots ML; METEOR Study Group.

J Hypertens. 2011 Nov;29(11):2181-93. doi: 10.1097/HJH.0b013e32834b0eba.

PMID:
21918474
16.

Sleep-time blood pressure: a validated therapeutic target.

Gradman AH.

J Am Coll Cardiol. 2011 Sep 6;58(11):1174-5. doi: 10.1016/j.jacc.2011.05.040. No abstract available.

17.

Difficult-to-Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies.

Papademetriou V, Tsioufis K, Gradman A, Punzi H.

Int J Hypertens. 2011;2011:438198. doi: 10.4061/2011/438198. Epub 2011 Jun 1.

18.

Manual or semi-automated edge detection of the maximal far wall common carotid intima-media thickness: a direct comparison.

Peters SA, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR 3rd, O'Leary DH, Evans GW, Raichlen JS, Lind L, Bots ML; METEOR Study Group.

J Intern Med. 2012 Mar;271(3):247-56. doi: 10.1111/j.1365-2796.2011.02422.x. Epub 2011 Aug 11.

PMID:
21726301
20.

Effect of number of ultrasound examinations on the assessment of carotid intima-media thickness changes over time: the example of the METEOR study.

Peters SA, Palmer MK, Grobbee DE, Crouse JR 3rd, Evans GW, Raichlen JS, Bots ML; METEOR Study Group.

J Hypertens. 2011 Jun;29(6):1145-54. doi: 10.1097/HJH.0b013e328345d85e.

PMID:
21546878
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk